News Headlines Article

Hepatitis C drug worth the price: Opposing view
USA Today

Rarely has a drug been introduced that represents a greater improvement in the standard of care than sofosbuvir (trade name Sovaldi). It is the cure that many of my patients have been waiting decades for.

Hepatitis C is a blood-borne virus that can live in patients for years without showing any symptoms, yet can eventually lead to cirrhosis, liver failure, liver cancer and death. It is the main cause of liver transplants in the U.S., which cost at least $145,000 and usually much more. And it is now killing more people every year than HIV/AIDS.